Literature DB >> 16134989

The extracellular deposition of mast cell products is increased in hypertrophic airways smooth muscles in allergic asthma but not in nonallergic asthma.

K Amin1, C Janson, G Boman, P Venge.   

Abstract

BACKGROUND: Bronchial asthma is characterized by airways smooth muscle hypertrophy and infiltration of mast cells in the bronchial mucosa. The aim of this investigation was to study the distribution of mast cells in different compartments in the bronchial mucosa of allergic and nonallergic asthma in relation to airways remodeling.
METHODS: Bronchial biopsies were obtained from 29 subjects with allergic and nonallergic asthma and healthy controls. The biopsies were stained for mast cells by means of the tryptase specific antibody AA1. Extracellular deposition of mast cell products were judged on a semi-quantitative scale. Mast cells per mm(2) were counted in epithelium, lamina propria and the smooth muscle compartment. Smooth muscle was visualized by actin antibodies and the proportion of staining of the biopsy estimated. Laminin and tenascin layers were visualized by their respective antibodies.
RESULTS: Airways smooth muscle thickness was greater in allergic vs nonallergic asthma (P < 0.001). Mast cells were increased in all three compartments in both allergic and nonallergic asthma, with significantly higher numbers in smooth muscles in allergic asthma (P < 0.03). The extracellular deposition of mast cell products was more common in allergic than nonallergic asthma in lamina propria and smooth muscles (P = 0.025; P = 0.002, respectively). In patients with allergic asthma the numbers of mast cells with extracellular deposition of mast cell products were significantly correlated to the thickness of the laminin and tenascin layers.
CONCLUSION: Our results suggest that there are large differences between allergic and nonallergic asthmatics as to mast cell activation and airways smooth muscle thickness. Our data implies that mast cells are causally involved in structural alterations in allergic asthma.

Entities:  

Mesh:

Year:  2005        PMID: 16134989     DOI: 10.1111/j.1398-9995.2005.00823.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  29 in total

Review 1.  Allergic Respiratory Inflammation and Remodeling.

Authors:  Kawa A M Amin
Journal:  Turk Thorac J       Date:  2015-07-01

Review 2.  Molecular regulation of mast cell development and maturation.

Authors:  Chenxiong Liu; Zhigang Liu; Zhilong Li; Yaojiong Wu
Journal:  Mol Biol Rep       Date:  2009-07-31       Impact factor: 2.316

Review 3.  Cytokine and anti-cytokine therapy in asthma: ready for the clinic?

Authors:  D Desai; C Brightling
Journal:  Clin Exp Immunol       Date:  2009-10       Impact factor: 4.330

4.  Potential Role of Mast Cells in Regulating Corticosteroid Insensitivity in Severe Asthma.

Authors:  Abdulrahman Alzahrani; Aamir Hussain; Fahad Alhadian; Jameel Hakeem; Sana Douaoui; Omar Tliba; Peter Bradding; Yassine Amrani
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  The αvβ6 integrin modulates airway hyperresponsiveness in mice by regulating intraepithelial mast cells.

Authors:  Kotaro Sugimoto; Makoto Kudo; Aparna Sundaram; Xin Ren; Katherine Huang; Xin Bernstein; Yanli Wang; Wilfred W Raymond; David J Erle; Magnus Abrink; George H Caughey; Xiaozhu Huang; Dean Sheppard
Journal:  J Clin Invest       Date:  2012-01-09       Impact factor: 14.808

6.  Asthma: eosinophil disease, mast cell disease, or both?

Authors:  Peter Bradding
Journal:  Allergy Asthma Clin Immunol       Date:  2008-06-15       Impact factor: 3.406

7.  Human airway smooth muscle promotes human lung mast cell survival, proliferation, and constitutive activation: cooperative roles for CADM1, stem cell factor, and IL-6.

Authors:  Fay Hollins; Davinder Kaur; Weidong Yang; Glenn Cruse; Ruth Saunders; Amanda Sutcliffe; Patrick Berger; Akihiko Ito; Christopher E Brightling; Peter Bradding
Journal:  J Immunol       Date:  2008-08-15       Impact factor: 5.422

Review 8.  Targeting TNF-alpha: a novel therapeutic approach for asthma.

Authors:  Christopher Brightling; Mike Berry; Yassine Amrani
Journal:  J Allergy Clin Immunol       Date:  2007-11-26       Impact factor: 10.793

Review 9.  Airway smooth muscle in asthma: just a target for bronchodilation?

Authors:  Judith L Black; Reynold A Panettieri; Audreesh Banerjee; Patrick Berger
Journal:  Clin Chest Med       Date:  2012-07-11       Impact factor: 2.878

10.  Schisandrin B down-regulated lncRNA BCYRN1 expression of airway smooth muscle cells by improving miR-150 expression to inhibit the proliferation and migration of ASMC in asthmatic rats.

Authors:  Xiao-Yu Zhang; Xue-Yi Tang; Li-Jun Ma; Ya-Li Guo; Xiao-Su Li; Li-Min Zhao; Cui-Jie Tian; Dong-Jun Cheng; Zhuo-Chang Chen; Luo-Xian Zhang
Journal:  Cell Prolif       Date:  2017-09-27       Impact factor: 6.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.